Noncanonical regulation of HOIL-1 on cancer stemness and sorafenib resistance identifies pixantrone as a novel therapeutic agent for HCC.
Chen P, Dong Z, Zhu W, Chen J, Zhou Y, Ye Q, Liao X, Tan Y, Li C, Wang Y, Pang H, Wen C, Jiang Y, Li X, Li B, Aimaier A, Lin L, Sun J, Hou J, Tang L, Hou J, Li Y.
Chen P, et al. Among authors: li c, li y, li x, li b.
Hepatology. 2024 Aug 1;80(2):330-345. doi: 10.1097/HEP.0000000000000623. Epub 2023 Oct 11.
Hepatology. 2024.
PMID: 37820061